Cytosorbents
CTSO
#10362
Rank
C$38.92 M
Marketcap
C$0.62
Share price
-8.11%
Change (1 day)
-60.98%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -C$18.2 Million

According to Cytosorbents's latest financial reports the company's current earnings are C$36.97 Million. In 2024 the company made an earning of -C$32.15 Million, an increase over its 2023 earnings that were of -C$41.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$18.2 Million-43.41%
2024 -C$32.15 Million-22.49%
2023 -C$41.47 Million-13.52%
2022 -C$47.96 Million34.04%
2021 -C$35.78 Million182.17%
2020 -C$12.68 Million-55.97%
2019 -C$28.8 Million14.17%
2018 -C$25.22 Million95.14%
2017 -C$12.93 Million-22.32%
2016 -C$16.64 Million39.1%
2015 -C$11.96 Million-12.89%
2014 -C$13.73 Million89%
2013 -C$7.27 Million26.65%
2012 -C$5.74 Million-26.02%
2011 -C$7.76 Million-288.45%
2010 C$4.11 M-4.17%
2009 C$4.29 M-287.19%
2008 -C$2.3 Million-47.12%
2007 -C$4.34 Million41.78%
2006 -C$3.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$5.29 B-29,618.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
C$1.09 B-6,233.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
C$78.5 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA